2014
DOI: 10.1016/j.transproceed.2014.04.014
|View full text |Cite
|
Sign up to set email alerts
|

Quality of Life and Psychology After Living-related Kidney Transplantation From Donors and Recipients in China

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 19 publications
0
4
0
1
Order By: Relevance
“…In a prospective study, Czyzewski et al [ 37 ] showed better physical HRQOL in the domain ‘physical functioning’ (PF) and better disease-specific HRQOL in the domain ‘burden of kidney disease’ (BKD) in KTRs at 3 and 12 months post-transplantation compared with patients receiving dialysis and found similar mental HRQOL in the two groups. The other studies in prevalent KTRs detected a significantly better HRQOL in various physical and/or mental domains [ 30–36 , 38–40 ]. Notably, only one study specified the WL status of its dialysis population and this study showed better physical [i.e.…”
Section: Resultsmentioning
confidence: 91%
“…In a prospective study, Czyzewski et al [ 37 ] showed better physical HRQOL in the domain ‘physical functioning’ (PF) and better disease-specific HRQOL in the domain ‘burden of kidney disease’ (BKD) in KTRs at 3 and 12 months post-transplantation compared with patients receiving dialysis and found similar mental HRQOL in the two groups. The other studies in prevalent KTRs detected a significantly better HRQOL in various physical and/or mental domains [ 30–36 , 38–40 ]. Notably, only one study specified the WL status of its dialysis population and this study showed better physical [i.e.…”
Section: Resultsmentioning
confidence: 91%
“…Over half of studies include people receiving in‐centre HD ( n = 460, 54.8%), with only 17 (2%; [Anvar‐Abnavi & Bazargani, 2010; Brekke et al, 2017; K.‐H. Chen et al, 2014; Danuser et al, 2017; Müller et al, 2020, Griva et al, 2012; Jones et al, 2020; Myaskovsky et al, 2012; Nohre et al, 2020; Schulz et al, 2014, 2017; Spencer et al, 2011; Szeifert et al, 2010; Zelle et al, 2012; Zheng et al, 2014; Zimmermann et al, 2016]) identifying depression in kidney transplant recipients. The most common type of depression assessment method was with a self‐report tool ( n = 716.…”
Section: Resultsmentioning
confidence: 99%
“…A total of 839 studies included data on the identification of depression (including the 102 studies that also had information on the identification and management of depression). A descriptive summary of these studies is presented in Müller et al, 2020, Griva et al, 2012Jones et al, 2020;Myaskovsky et al, 2012;Nohre et al, 2020;Schulz et al, 2014Schulz et al, , 2017Spencer et al, 2011;Szeifert et al, 2010;Zelle et al, 2012;Zheng et al, 2014;Zimmermann et al, 2016]) identifying depression in kidney transplant recipients. The most common type of depression assessment method was with a self-report tool (n = 716.…”
Section: Identification Of Depression: Study Characteristicsmentioning
confidence: 99%
“…Enfin, bien que certaines revues systématiques [7,15] s'accordent sur le fait que le niveau de QdV des patients TR soit meilleur que celui des patients HD, les résultats sont plus nuancés en ce qui concerne la comparaison du niveau de QdV des patients TR à celui de la population générale. En effet, certaines études [16,17] ont montré que le niveau de QdV des patients TR est comparable à celui de contrôles sains, alors que d'autres études plus récentes [18,19] ont trouvé un niveau de QdV inferieur. L'analyse de données qualitatives corroborent la disparité des résultats quantitatifs précités, car, si les patients TR soulignent les bénéfices à vivre avec un rein transplanté (sentiment de « renaissance », regain d'énergie, relaxation physique et psychologique, joie et espoir), ils rapportent également des difficultés, telles un sentiment de culpabilité, des désillusions liées aux effets secondaires des immunosuppresseurs, la responsabilité morale du maintien en santé, l'anxiété due à la possible perte du greffon (et du retour en HD), ainsi que le non-retour au rôle social attendu par les proches [20][21][22].…”
Section: Introductionunclassified